C. Griffiths

发表

Determinants of pre-vaccination antibody responses to SARS-CoV-2: a population-based longitudinal study (COVIDENCE UK)

David A. Jolliffe, M. Talaei, F. Kee, 2021, BMC Medicine.

1α,25‐dihydroxyvitamin D3 inhibits matrix metalloproteinases induced by Mycobacterium tuberculosis infection

R. Wilkinson, B. Boucher, P. Timms, 2009, Immunology.

Vitamin D in the treatment and prevention of tuberculosis

R. Wilkinson, A. Martineau, C. Griffiths, 2008, Expert review of endocrinology & metabolism.

Vitamin D Metabolism is Dysregulated in Asthma and Chronic Obstructive Pulmonary Disease.

John H. White, David A. Jolliffe, Yike Guo, 2020, American journal of respiratory and critical care medicine.

Vitamin D for secondary prevention of acute wheeze attacks in preschool and school-age children

A. Bush, C. Nwokoro, A. Martineau, 2019, Thorax.

Vitamin D attenuates rhinovirus-induced expression of intercellular adhesion molecule-1 (ICAM-1) and platelet-activating factor receptor (PAFR) in respiratory epithelial cells

David A. Jolliffe, S. Johnston, T. Kebadze, 2019, The Journal of Steroid Biochemistry and Molecular Biology.

Effect of a test-and-treat approach to vitamin D supplementation on risk of all cause acute respiratory tract infection and covid-19: phase 3 randomised controlled trial (CORONAVIT)

David A. Jolliffe, J. Norrie, M. Talaei, 2022, BMJ.

Serum 25-dihydroxyvitamin D levels correlate with CD4(+)Foxp3(+) T-cell numbers in moderate/severe asthma.

C. Hawrylowicz, P. Timms, E. S. Chambers, 2012, The Journal of allergy and clinical immunology.

Neutrophilia independently predicts death in tuberculosis

R. Wilkinson, R. Barker, D. Lowe, 2013, European Respiratory Journal.

Calcitriol restores glucocorticoid responsiveness in steroid resistant asthmatics through reduction of IL-17A

P. Pfeffer, C. Hawrylowicz, E. S. Chambers, 2014 .

Determinants of Antibody Responses to SARS-CoV-2 Vaccines: Population-Based Longitudinal Study (COVIDENCE UK)

David A. Jolliffe, M. Talaei, F. Kee, 2022, Vaccines.

Vitamin D supplementation to prevent acute respiratory infections: a systematic review and meta-analysis of aggregate data from randomised controlled trials.

David A. Jolliffe, A. Ginde, J. Aloia, 2021, The lancet. Diabetes & endocrinology.

Double-blind randomised placebo-controlled trial of bolus-dose vitamin D3 supplementation in adults with asthma (ViDiAs)

David A. Jolliffe, A. Bhowmik, C. Hawrylowicz, 2015, Thorax.

Enhanced production of IL-17A in patients with severe asthma is inhibited by 1α,25-dihydroxyvitamin D3 in a glucocorticoid-independent fashion.

C. Hawrylowicz, P. Timms, E. S. Chambers, 2013, The Journal of allergy and clinical immunology.

Association between short-term NO exposure and asthma exacerbations in East London: A time series regression model

A. De Simoni, B. Heydecker, C. Griffiths, 2022, Urban Climate.

A single dose of vitamin D enhances immunity to mycobacteria.

Robert J Wilkinson, Beate Kampmann, Sandra M Eldridge, 2007, American journal of respiratory and critical care medicine.

Vitamin D supplementation to prevent acute respiratory tract infections: systematic review and meta-analysis of individual participant data

David A. Jolliffe, C. Camargo, A. Ginde, 2017, British Medical Journal.

Vitamin D supplementation to prevent acute respiratory infections: individual participant data meta-analysis.

David A. Jolliffe, C. Camargo, A. Ginde, 2019, Health technology assessment.

Vitamin D supplementation to prevent acute respiratory infections: systematic review and meta-analysis of aggregate data from randomised controlled trials

David A. Jolliffe, A. Ginde, J. Aloia, 2020, medRxiv.

Double-blind randomised controlled trial of vitamin D3 supplementation for the prevention of acute respiratory infection in older adults and their carers (ViDiFlu)

David A. Jolliffe, Aishah Knight, P. Timms, 2015, Thorax.

IFN--and TNF-Independent Vitamin D-Inducible Human Suppression of Mycobacteria: The Role of Cathelicidin LL-37

R. Wilkinson, A. Norman, R. Floto, 2007 .

Vitamin D to prevent exacerbations of COPD: systematic review and meta-analysis of individual participant data from randomised controlled trials

David A. Jolliffe, C. Camargo, W. Janssens, 2019, Thorax.

High-dose vitamin D3 during intensive-phase antimicrobial treatment of pulmonary tuberculosis: a double-blind randomised controlled trial

R. Wilkinson, F. Drobniewski, P. Timms, 2011, The Lancet.

Distinct endotypes of steroid-resistant asthma characterized by IL-17Ahigh and IFN-γhigh immunophenotypes: Potential benefits of calcitriol

P. Pfeffer, C. Hawrylowicz, P. Timms, 2015, The Journal of allergy and clinical immunology.

The effects of calcitriol treatment in glucocorticoid-resistant asthma.

C. Hawrylowicz, P. Timms, E. S. Chambers, 2014, The Journal of allergy and clinical immunology.

Prevalence, determinants and clinical correlates of vitamin D deficiency in patients with Chronic Obstructive Pulmonary Disease in London, UK

David A. Jolliffe, A. Bhowmik, R. Walton, 2018, The Journal of Steroid Biochemistry and Molecular Biology.

Longitudinal study of vitamin D metabolites after long bone fracture

A. Norman, P. Timms, R. Vieth, 2013, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Prevalence, determinants and clinical correlates of vitamin D deficiency in adults with inhaled corticosteroid-treated asthma in London, UK

David A. Jolliffe, A. Bhowmik, E. Hyppönen, 2018, The Journal of Steroid Biochemistry and Molecular Biology.

Improved vitamin D status despite allocation to placebo in a tuberculosis treatment trial: contamination bias?

A. Martineau, G. Packe, C. Griffiths, 2009, American journal of respiratory and critical care medicine.

Safety of ondansetron.

A. Jukes, W. Castle, C. Griffiths, 1992, European journal of anaesthesiology. Supplement.

Single nucleotide polymorphisms in the vitamin D pathway associating with circulating concentrations of vitamin D metabolites and non-skeletal health outcomes: Review of genetic association studies

David A. Jolliffe, R. Walton, A. Martineau, 2016, The Journal of Steroid Biochemistry and Molecular Biology.

Neutrophil-mediated innate immune resistance to mycobacteria.

R. Wilkinson, A. Martineau, G. Packe, 2007, The Journal of clinical investigation.

Risk factors for developing COVID-19: a population-based longitudinal study (COVIDENCE UK)

David A. Jolliffe, G. Breen, R. Lyons, 2021, Thorax.

Association between Gc genotype and susceptibility to TB is dependent on vitamin D status

S. Anderson, S. Pienaar, R. Wilkinson, 2009, European Respiratory Journal.

Vitamin D accelerates resolution of inflammatory responses during tuberculosis treatment

R. Wilkinson, F. Drobniewski, Leena Bhaw-Rosun, 2012, Proceedings of the National Academy of Sciences.

Vitamin D supplementation to prevent asthma exacerbations: a systematic review and meta-analysis of individual participant data.

Mitsuyoshi Urashima, David A. Jolliffe, C. Camargo, 2017, The Lancet. Respiratory medicine.

IFN-γ- and TNF-Independent Vitamin D-Inducible Human Suppression of Mycobacteria: The Role of Cathelicidin LL-371

Robert J Wilkinson, Beate Kampmann, R. Wilkinson, 2007, The Journal of Immunology.

Dendritic cell phenotype in severe asthma reflects clinical responsiveness to glucocorticoids

P. Pfeffer, C. Hawrylowicz, E. S. Chambers, 2017, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

Environmental and genetic determinants of vitamin D status among older adults in London, UK

David A. Jolliffe, R. Walton, E. Hyppönen, 2016, The Journal of Steroid Biochemistry and Molecular Biology.

Vitamin D for the management of asthma.

David A. Jolliffe, A. Martineau, C. Griffiths, 2023, The Cochrane database of systematic reviews.

Vitamin D in the prevention of acute respiratory infection: Systematic review of clinical studies

David A. Jolliffe, A. Martineau, C. Griffiths, 2013, The Journal of Steroid Biochemistry and Molecular Biology.

Nanzer et al 1 Enhanced production of IL-17A in severe asthma is inhibited by 1 α,25-dihydroxyvitamin D3 in a glucocorticoid-independent fashion

C. Hawrylowicz, P. Timms, A. Martineau, 2017 .

Vitamin D3 supplementation in patients with chronic obstructive pulmonary disease (ViDiCO): a multicentre, double-blind, randomised controlled trial.

David A. Jolliffe, A. Bhowmik, C. Hawrylowicz, 2015, The Lancet. Respiratory medicine.

Vitamin D Supplements for Prevention of Covid-19 or other Acute Respiratory Infections: a Phase 3 Randomized Controlled Trial (CORONAVIT)

P. Pfeffer, C. Relton, S. Faustini, 2022, medRxiv.

The effects of vitamin D2 or D3 supplementation on glycaemic control and related metabolic parameters in people at risk of type 2 diabetes: protocol of a randomised double-blind placebo-controlled trial

G. Hitman, T. Chowdhury, S. Sharp, 2013, BMC Public Health.

Effects of vitamin D2 or D3 supplementation on glycaemic control and cardiometabolic risk among people at risk of type 2 diabetes: results of a randomized double‐blind placebo‐controlled trial

G. Hitman, T. Chowdhury, S. Sharp, 2016, Diabetes, obesity & metabolism.

Risk factors for SARS-CoV-2 infection after primary vaccination with ChAdOx1 nCoV-19 or BNT162b2 and after booster vaccination with BNT162b2 or mRNA-1273: A population-based cohort study (COVIDENCE UK)

David A. Jolliffe, M. Talaei, F. Kee, 2022, The Lancet Regional Health - Europe.

Ethnic Variation in Inflammatory Profile in Tuberculosis

R. Wilkinson, F. Drobniewski, Leena Bhaw-Rosun, 2013, PLoS pathogens.

Vitamin D receptor genotype influences risk of upper respiratory infection.

David A. Jolliffe, A. Custovic, S. Johnston, 2018, The British journal of nutrition.

Incidence determinants and serological correlates of reactive symptoms following SARS-CoV-2 vaccination

David A. Jolliffe, M. Talaei, F. Kee, 2023, npj Vaccines.

Rebound in asthma exacerbations following relaxation of COVID-19 restrictions: a longitudinal population-based study (COVIDENCE UK)

David A. Jolliffe, M. Talaei, P. Pfeffer, 2022, Thorax.

Cohort Profile: Longitudinal population-based study of COVID-19 in UK adults (COVIDENCE UK)

David A. Jolliffe, G. Breen, M. Talaei, 2022, medRxiv.

Determinants of antibody responses to two doses of ChAdOx1 nCoV-19 or BNT162b2 and a subsequent booster dose of BNT162b2 or mRNA-1273: population-based cohort study (COVIDENCE UK)

David A. Jolliffe, M. Talaei, F. Kee, 2022, medRxiv.

Vitamin D in the treatment of pulmonary tuberculosis

R. Wilkinson, F. Honecker, A. Martineau, 2007, The Journal of Steroid Biochemistry and Molecular Biology.

Influence of a single oral dose of vitamin D(2) on serum 25-hydroxyvitamin D concentrations in tuberculosis patients.

R. Wilkinson, S. Eldridge, P. Timms, 2009, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

Social Medical Capital: How Patients and Caregivers Can Benefit From Online Social Interactions (Preprint)

Nishanth R. Sastry, P. Panzarasa, A. De Simoni, 2019 .

Device-Measured Change in Physical Activity in Primary School Children During the UK COVID-19 Pandemic Lockdown: A Longitudinal Study

S. Beevers, E. V. van Sluijs, S. Eldridge, 2023, Journal of physical activity & health.

Vitamin D to prevent COVID-19 or other acute respiratory infections: phase 3 randomised controlled trial (CORONAVIT)

S. Shaheen, A. Martineau, M. Talaei, 2022, 10.01 - Respiratory infections and bronchiectasis.

High-dose vitamin D3 during intensive phase treatment of pulmonary tuberculosis: a double-blind randomised controlled trial

J. Heather, D. Phil., F. Drobniewski, 2014 .